Company intelligence / Profile preview

Glovax Biotech

Quezon City, Metro Manila, Philippines

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Glovax Biotech is a fully integrated vaccine company operating in the Philippines, distributing and retailing WHO-prequalified vaccines aimed at improving access and affordability for low- and middle-income populations. It has distributed over 7 million vaccine doses, focusing on reducing vaccine costs by as much as 75% and expanding access through vaccination centers and mobile clinics. The company is a recognized leader in the logistics and supply of vaccines in underserved markets, particularly for routine immunizations.[1][2][3][4]

Therapeutic areas: Infectious Diseases
Modalities: Vaccine
Industry: Non-Academic Healthcare

Partnerships

Philippines Government (public-private partnerships for local vaccine manufacturing)[3]Civil society organizations

Beyond the preview

Go deeper on Glovax Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glovax Biotech.

Explore the full profile